Open Access

Cardiac fibrosis and atrial fibrillation

Klaudia Katarzyna Mickiewicz

Klaudia Katarzyna Mickiewicz

Medical University of Białystok, Cardiology DepartmentBiałystok, Poland
Orcid profile
Search for this author on
Sciendo|Google Scholar
Mickiewicz, Klaudia Katarzyna
, 
Anna Lisowska

Anna Lisowska

Medical University of Białystok, Cardiology DepartmentBiałystok, Poland
Orcid profile
Search for this author on
Sciendo|Google Scholar
Lisowska, Anna
 and 
Małgorzata Knapp

Małgorzata Knapp

Medical University of Białystok, Cardiology DepartmentBiałystok, Poland
Orcid profile
Search for this author on
Sciendo|Google Scholar
Knapp, Małgorzata
  
Jul 11, 2022
Cardiac fibrosis and atrial fibrillation's Cover Image
About this article
Previous Article
Next Article
Cite
Download Cover
Article Category: Review
Published Online: Jul 11, 2022
Page range: 307 - 314
Received: Oct 28, 2021
Accepted: Mar 28, 2022
DOI: https://doi.org/10.2478/ahem-2022-0035
Keywords
© 2022 Klaudia Katarzyna Mickiewicz et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Fig. 1

Fibroblast growth factor (FGF)-23 and its effect on cardiac fibroblast activity.FGF receptor 1 (FGFR1), phospholipase C (PLC), inositol 1,4,5-trisphosphate (IP3), calcium channel protein 1 (Orai1), IP3 receptor (IP3R)
Fibroblast growth factor (FGF)-23 and its effect on cardiac fibroblast activity.FGF receptor 1 (FGFR1), phospholipase C (PLC), inositol 1,4,5-trisphosphate (IP3), calcium channel protein 1 (Orai1), IP3 receptor (IP3R)
Language:
English
Publication timeframe:
1 times per year
Journal Subjects:
Life Sciences, Molecular Biology, Microbiology and Virology, Medicine, Basic Medical Science, Immunology
Journal RSS Feed